http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 16 Oct 2026 06:06:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/27195315.html si-local-file:///var/storage/secattach/20261016/27195315.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/27195315.html Fri, 16 Oct 2026 06:06:00 -0400 GDTC http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/27176444.html si-local-file:///var/storage/secattach/20261013/27176444.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/27176444.html Tue, 13 Oct 2026 06:14:00 -0400 GDTC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Oct+09/27176193.html si-local-file:///var/storage/secattach/20261013/27176193.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Oct+09/27176193.html Tue, 13 Oct 2026 06:01:00 -0400 GDTC http://www.streetinsider.com/Corporate+News/CytoMed+Therapeutics+receives+Nasdaq+minimum+bid+price+notice/27171846.html <p>CytoMed Therapeutics Limited (NASDAQ: GDTC), a Singapore-based clinical-stage biopharmaceutical company, announced it received a notice from Nasdaq on October 6, 2026, stating that the closing bid price of its ordinary shares had fallen below the required minimum of $1.00 per share for 30 consecutive business days, in violation of Nasdaq Listing Rule 5550(a)(2).</p> <p>According to the company's statement, the notification does not currently affect the listing or trading of its ordinary shares on Nasdaq.</p> <p>Under Nasdaq Listing Rule 5810(c)(3)(A), the company has 180 calendar days, until April 5, 2027, to regain compliance. Compliance can be achieved if the closing bid price of http://www.streetinsider.com/Corporate+News/CytoMed+Therapeutics+receives+Nasdaq+minimum+bid+price+notice/27171846.html Fri, 09 Oct 2026 16:30:12 -0400 GDTC http://www.streetinsider.com/Press+Releases/CytoMed+Therapeutics+Limited+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/27171830.html <p align="justify">SINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived, cell-based allogeneic immunotherapies, today announced that on October 6, 2026, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the closing bid price of the Company’s ordinary shares (the “Ordinary Shares”) was below the minimum bid price of US$1.00 per share requirement set forth in http://www.streetinsider.com/Press+Releases/CytoMed+Therapeutics+Limited+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/27171830.html Fri, 09 Oct 2026 16:30:00 -0400 GDTC http://www.streetinsider.com/Globe+Newswire/CytoMed+Therapeutics+Limited+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/27171830.html <p align="justify">SINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived, cell-based allogeneic immunotherapies, today announced that on October 6, 2026, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the closing bid price of the Company’s ordinary shares (the “Ordinary Shares”) was below the minimum bid price of US$1.00 per share requirement set forth in http://www.streetinsider.com/Globe+Newswire/CytoMed+Therapeutics+Limited+Announces+Receipt+of+Nasdaq+Notification+Regarding+Minimum+Bid+Price+Deficiency/27171830.html Fri, 09 Oct 2026 16:30:00 -0400 GDTC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+30/27126463.html si-local-file:///var/storage/secattach/20260930/27126463.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+30/27126463.html Wed, 30 Sep 2026 09:15:00 -0400 GDTC http://www.streetinsider.com/SEC+Filings/Form++144++++++++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+mDR+Ltd/26903503.html si-local-file:///var/storage/secattach/20260811/26903503.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+mDR+Ltd/26903503.html Tue, 11 Aug 2026 10:38:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+mDR+Ltd/26903503.html si-local-file:///var/storage/secattach/20260811/26903503.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+mDR+Ltd/26903503.html Tue, 11 Aug 2026 10:38:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26814563.html si-local-file:///var/storage/secattach/20260724/26814563.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26814563.html Fri, 24 Jul 2026 21:01:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26814563.html si-local-file:///var/storage/secattach/20260724/26814563.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26814563.html Fri, 24 Jul 2026 21:01:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/26812599.html si-local-file:///var/storage/secattach/20260724/26812599.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/26812599.html Fri, 24 Jul 2026 12:42:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/26812599.html si-local-file:///var/storage/secattach/20260724/26812599.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++CytoMed+Therapeutics+++++++++++++++++++Filed+by%3A+Choo+Chee+Kong/26812599.html Fri, 24 Jul 2026 12:42:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26812579.html si-local-file:///var/storage/secattach/20260724/26812579.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26812579.html Fri, 24 Jul 2026 12:34:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26812579.html si-local-file:///var/storage/secattach/20260724/26812579.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jul+14++Filed+by%3A+Choo+Chee+Kong/26812579.html Fri, 24 Jul 2026 12:34:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+23/26678212.html si-local-file:///var/storage/secattach/20260623/26678212.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+23/26678212.html Tue, 23 Jun 2026 12:14:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+23/26678212.html si-local-file:///var/storage/secattach/20260623/26678212.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+23/26678212.html Tue, 23 Jun 2026 12:14:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jun+08++Filed+by%3A+Choo+Chee+Kong/26643847.html si-local-file:///var/storage/secattach/20260615/26643847.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jun+08++Filed+by%3A+Choo+Chee+Kong/26643847.html Mon, 15 Jun 2026 06:15:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jun+08++Filed+by%3A+Choo+Chee+Kong/26643847.html si-local-file:///var/storage/secattach/20260615/26643847.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CytoMed+Therapeutics++++++For%3A+Jun+08++Filed+by%3A+Choo+Chee+Kong/26643847.html Mon, 15 Jun 2026 06:15:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+03/26598753.html si-local-file:///var/storage/secattach/20260603/26598753.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+03/26598753.html Wed, 03 Jun 2026 16:05:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+03/26598753.html si-local-file:///var/storage/secattach/20260603/26598753.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CytoMed+Therapeutics++++++For%3A+Jun+03/26598753.html Wed, 03 Jun 2026 16:05:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+Toh+Keng+Kiat/26546796.html si-local-file:///var/storage/secattach/20260526/26546796.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+Toh+Keng+Kiat/26546796.html Tue, 26 May 2026 09:00:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+Toh+Keng+Kiat/26546796.html si-local-file:///var/storage/secattach/20260526/26546796.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+Toh+Keng+Kiat/26546796.html Tue, 26 May 2026 09:00:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+TAN+YOONG+YING/26500463.html si-local-file:///var/storage/secattach/20260515/26500463.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+TAN+YOONG+YING/26500463.html Fri, 15 May 2026 09:01:00 -0400 GDTC O.38183177 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+TAN+YOONG+YING/26500463.html si-local-file:///var/storage/secattach/20260515/26500463.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CytoMed+Therapeutics++++++For%3A+Mar+18++Filed+by%3A+TAN+YOONG+YING/26500463.html Fri, 15 May 2026 09:01:00 -0400 GDTC O.38183177